Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries

NCT07258290 is registered in ClinicalTrials.gov with Teleflex as lead sponsor.

NCT NCT07258290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries
Lead sponsor
Teleflex
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2026
Completion date
June 30, 2033
Enrollment
1,859 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, angina pectoris, arterial occlusive diseases, arteriosclerosis, cardiovascular diseases, chest pain, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, neurologic manifestations, pain, pathological conditions, signs and symptoms, signs and symptoms, vascular diseases